<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Rowset rowCount='1'><Row><ArmCount>1+</ArmCount><Biomarkers>Blood pressure; Estimated glomerular filtration rate</Biomarkers><Condition>Cardiovascular disease</Condition><Controls/><DevStatus id="C4">Phase 4 Clinical</DevStatus><Drug id="56641">benidipine</Drug><EnrollmentCount>3501</EnrollmentCount><Interventions>angiotensin receptor blockers; benidipine; benidipine + angiotensin receptor blockers or beta-blockers or thiazide diuretics; beta-blockers; thiazide diuretics</Interventions><Patients>3293</Patients><ProtocolAcronym>COPE</ProtocolAcronym><ProtocolTitle>Benidipine-based Comparison of Angiotensin Receptors, Beta-blockers, or Thiazide Diuretics in Hypertensive Patients</ProtocolTitle><Reference>COPE; NCT00135551; UMIN000001152; copeadministrator</Reference><Sponsor>COPE Trial Group</Sponsor><Trial id="79942"/><TrialStartDate>MAY      , 31, 2003</TrialStartDate><TrialStatus>Completed</TrialStatus></Row></Rowset>